Evidence map›Paper›PMID 35892945›Full record

ReviewMarine drugs2022

Therapeutic Potential of Marine Bioactive Peptides against Human Immunodeficiency Virus: Recent Evidence, Challenges, and Future Trends.

Jameel Mohammed Al-Khayri, Waqas Asghar, Sipper Khan, Aqsa Akhtar, Haris Ayub, Nauman Khalid, Fatima Mohammed Alessa, Muneera Qassim Al-Mssallem, Adel Abdel-Sabour Rezk, Wael Fathi Shehata

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Insights into Common Octopus (Marine drugs · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jameel Mohammed Al-KhayriDepartment of Plant Biotechnology, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0001-9507-0201
Waqas AsgharSchool of Food and Agricultural Sciences, University of Management and Technology, Lahore 54770, Pakistan.ORCID 0000-0002-2337-6612
Sipper KhanSchool of Food and Agricultural Sciences, University of Management and Technology, Lahore 54770, Pakistan.ORCID 0000-0001-9703-3949
Aqsa AkhtarSchool of Food and Agricultural Sciences, University of Management and Technology, Lahore 54770, Pakistan.
Haris AyubSchool of Food and Agricultural Sciences, University of Management and Technology, Lahore 54770, Pakistan.
Nauman KhalidSchool of Food and Agricultural Sciences, University of Management and Technology, Lahore 54770, Pakistan.ORCID 0000-0002-8045-199X
Fatima Mohammed AlessaDepartment of Food Science and Nutrition, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Muneera Qassim Al-MssallemDepartment of Food Science and Nutrition, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Adel Abdel-Sabour RezkDepartment of Plant Biotechnology, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Wael Fathi ShehataDepartment of Plant Biotechnology, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
King Faisal University · SAUniversity of Management and Technology · PK

Funding

King Faisal University AN000571
6 · The paper itself

Abstract

Acquired immunodeficiency syndrome (AIDS) is a chronic and potentially fatal ailment caused by the human immunodeficiency virus (HIV) and remains a major health problem worldwide. In recent years, the research focus has shifted to a greater emphasis on complementing treatment regimens involving conventional antiretroviral (ARV) drug therapies with novel lead structures isolated from various marine organisms that have the potential to be utilized as therapeutics for the management of HIV-AIDS. The present review summarizes the recent developments regarding bioactive peptides sourced from various marine organisms. This includes a discussion encompassing the potential of these novel marine bioactive peptides with regard to antiretroviral activities against HIV, preparation, purification, and processing techniques, in addition to insight into the future trends with an emphasis on the potential of exploration and evaluation of novel peptides to be developed into effective antiretroviral drugs.

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsAquatic OrganismsHIVHumansPeptidesAnti-HIV AgentsPeptidesanti-HIVantiretroviral agentsbioactive peptidesdrugsmarine organisms

Identifiers

PMID35892945
PMCPMC9394390
OpenAlexW4287831811

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.